Provided are uses of compositions comprising shortened poly-N-acetylglucosamine nanofibers (sNAG nanofibers), for the treatment of cosmetic and therapeutic conditions of the skin and connective tissue. The compositions can be used for increasing tensile strength and/or elasticity of tissue or for treating a disease or condition associated with reduced tensile strength and/or elasticity of tissue.